In such emergencies, immediate action is crucial. One of the most important tools for people with severe allergies is an epinephrine auto-injector (EAI). These devices deliver a dose of epinephrine, ...

The previous update I wrote on Novartis was the Q2 earnings preview ... from an earlier launch should be very limited. I expect Kesimpta sales to grow nearly 30% at the mid-point of my estimate ...

Reactions after the injection ... Kesimpta® (ofatumumab), Similar to Ocrevus®, for Relapsing MS,” “Non-approved treatments used for MS disease modification,” “Ocrevus.” Novartis ...

You’ll get meds before your injection to help with side effects ... antibodies in autoimmune disease treatment.” Novartis: “Kesimpta Medication Guide.” Multiplesclerosis.net: "Rituximab ...

With the ability to accommodate injection volumes up to 5ml and high-viscosity fluids of up to 1000cP, the platform is built to handle the increasing demands for larger injection sizes and fast ...

South Carolina Dept. of Corrections via AP) COLUMBIA, S.C. (AP) — A condemned South Carolina inmate chose Friday to be executed by lethal injection, instead of by firing squad or electrocution, for ...

Last month, Novartis released new data from the ALITHIOS open-label extension study. Data show first-line Kesimpta (ofatumumab) treatment for up to six years led to less disability and disease ...

Stevanato Group S.p.A. signed an exclusive agreement for its Aidaptus auto-injector with leading medical device developer and manufacturer Owen Mumford Ltd. in May 2022. Aidaptus is a two-step, single ...

If approved, Kisqali could nearly double the number of patients eligible for CDK4/6 inhibitor adjuvant therapy,” said Patrick Horber M.D., President, International, Novartis. “Together with the recent ...